Curing Plasmodium vivax malaria

Professor Ric Price, affiliated with our OUCRU unit, tells us of his research on surveillance, diagnostics and treatments for Plasmodium vivax malaria Vivax malaria used to be considered benign but is now recognised as an important cause of morbidity and mortality. Resistance to chloroquine (given to treat the parasite blood stage) is growing and ACT (artemisinin-based combination therapy) is becoming common treatment for vivax malaria. New drugs and better public health strategies can help elimination targets, anticipated for 2030.

You can listen to Curing Plasmodium vivax malaria online on Radio and Podcast. Open the player on this page to stream the available audio.

Curing Plasmodium vivax malaria is an episode from Malaria by Oxford University.

This episode is 4:09 long.

This episode was published on Jul 12, 2019.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Malaria when more episodes are available from the podcast feed.